603108 润达医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-2.350-13.4731.2806.69111.365
总资产报酬率 ROA (%)-0.672-3.9560.3861.8963.149
投入资产回报率 ROIC (%)-0.832-4.9020.4842.4384.057

边际利润分析
销售毛利率 (%)24.48921.38925.36526.55427.990
营业利润率 (%)0.017-6.4344.2607.0717.779
息税前利润/营业总收入 (%)4.148-2.6747.92810.62910.894
净利润/营业总收入 (%)-1.923-7.4042.2794.8396.242

收益指标分析
经营活动净收益/利润总额(%)-622.71521.91491.73975.566103.841
价值变动净收益/利润总额(%)-232.548-4.51431.78235.39016.720
营业外收支净额/利润总额(%)105.2512.254-2.4651.3350.400

偿债能力分析
流动比率 (X)1.0651.1091.2201.2481.154
速动比率 (X)0.8470.8841.0441.0650.964
资产负债率 (%)63.13363.61960.82561.93465.494
带息债务/全部投入资本 (%)61.33762.97559.92760.04463.452
股东权益/带息债务 (%)58.49455.49962.95863.12155.095
股东权益/负债合计 (%)45.95844.35350.04548.29340.892
利息保障倍数 (X)0.926-0.6842.1023.0703.533

营运能力分析
应收账款周转天数 (天)248.148248.493232.505225.516165.206
存货周转天数 (天)124.71799.96078.35480.18674.276